Skip to main content
Tech.euFundingExplorerBeta

ViCentra

ViCentra has developed an insulin pump for diabetes patients.

ViCentra has raised €159M across 4 funding rounds from 10 investors, most recently a Series D+ round in Jan 2026. Based in Utrecht, Netherlands; founded 2013; active in Healthtech. Data as of 28 Oct 2026.

Utrecht, NetherlandsFounded 2013www.vicentra.com ↗
Total raised
€159M
€159,115,071
Funding rounds
4
Investors
10
distinct backers
Active since
2020-07
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
ViCentra — funding by year — interactive chart.
Data table
ViCentra — funding by year
2020€10M
2021€65M
2025€73M
2026€11M

Signals

High confidence
Raise-next likelihood58
base rate 53% for Series D+
  • ▲ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood24
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 4 rounds raised
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData